期刊文献+

血管内皮生长因子C过表达或抑制表达对人小细胞肺癌NCI-H446细胞生物学行为的影响 被引量:10

Influences of over-expression of VEGF-C and its inhibition on biological characteristics of NCI-H446 human small-cell lung cancer cells
原文传递
导出
摘要 目的:探讨血管内皮生长因子C(vascular endothelial growth factorC,VEGF-C)对人小细胞肺癌细胞株NCI-H446生长、体外侵袭和细胞凋亡的影响。方法:构建VEGF-C过表达慢病毒质粒pHRi-VEGF-C和小干扰RNA(small interference RNA,siRNA)慢病毒表达质粒pHRi-siVEGF-C,经慢病毒包装后分别感染NCI-H446细胞。蛋白质印迹法检测VEGF-C的表达水平,MTT方法检测细胞增殖活性,Transwell实验检测细胞体外侵袭能力,FCM检测细胞凋亡比例。结果:与空载体对照组相比,pHRi-VEGF-C质粒感染入NCI-H446细胞后VEGF-C基因表达水平显著升高,而pHRi-siVEGF-C质粒感染后VEGF-C基因表达水平显著降低。pHRi-VEGF-C质粒感染第5天后,NCI-H446细胞增殖(D值=1.481±0.056)明显高于pHRi-siVEGF-C组(D值=0.838±0.035)和空载体对照组(D值=1.146±0.07),差异有统计学意义(P<0.05);pHRi-siVEGF-C组中每个视野侵袭的细胞平均数为39.78±0.77,显著低于pHRi-VEGF-C组的84.87±1.27和空载体对照组的60.82±1.05,差异有统计学意义(P<0.01)。感染了pHRi-VEGF-C质粒后的NCI-H446细胞凋亡数较空载体对照组减少约90%,差异有统计学意义(P<0.01)。结论:VEGF-C过表达可以显著促进NCI-H446细胞增殖,增强其侵袭能力,抑制细胞凋亡;而VEGF-C表达经RNA干扰后可以显著减缓细胞的增殖趋势,降低NCI-H446细胞的侵袭能力。推测VEGF-C可能成为临床治疗小细胞肺癌的基因治疗靶点之一。 Objective:To investigate the influences of vascular endothelial growth factor C(VEGF-C) on cell proliferation,invasion and apoptosis of NCI-H446 human small-cell lung cancer(SCLC) cells in vitro.Methods:The plasmids for VEGF-C overexpression(pHRi-VEGF-C) and small RNA interference targeting VEGF-C(pHRi-siVEGF-C) were constructed.Then the NCI-H446 cells were infected with the lentiviral packaging plasmids pHRi(an empty vector),pHRi-VEGF-C and pHRi-siVEGF-C,respectively.The expression of VEGF-C was examined by Western blotting;the cell proliferation was detected by MTT method;the invasive ability was detected by Transwell assay;and the apoptosis rate was determined by flow cytometry(FCM).Results:The expression level of VEGF-C protein in the NCI-H446 cells was significantly increased after lentiviral packaging plasmid pHRi-VEGF-C infection while it was significantly decreased after lentiviral packaging plasmid pHRi-siVEGF-C infection.The cell proliferation was significantly increased after the NCI-H446 cells were infected with pHRi-VEGF-C for five days as compared with that of the NCI-H446 cells infected with pHRi-siVEGF-C or pHRi(1.481±0.056,0.838±0.035 and 1.146±0.07;P 0.05).The average number of invasive cells in each visual field was significantly reduced in the pHRi-siVEGF-C-infected NCI-H446 cells as compared with that of the pHRi-VEGF-C-or pHRi-infected NCI-H446 cells(39.78±0.77,84.87±1.27 and 60.82±1.05;P 0.01).The number of apoptotic cells was also reduced by 90% in the pHRi-VEGF-C-infected NCI-H446 cells as compared with that of the pHRi-infected NCI-H446 cells(P 0.01).Conclusion:The overexpression of VEGF-C can obviously promote the proliferative and invasive abilities of NCI-H446 cells,and it also can reduce the apoptosis.Meanwhile,these effects can be inhibited by small RNA interference targeting VEGF-C.The results suggest that VEGF-C may become a target of gene treatment for small-cell lung cancer.
出处 《肿瘤》 CAS CSCD 北大核心 2012年第2期79-84,共6页 Tumor
基金 上海市自然科学基金资助项目(编号:09ZR142600)
关键词 小细胞肺 血管内皮生长因子C 基因表达 RNA干扰 细胞增殖 细胞凋亡 肿瘤侵润 Carcinoma small-cell lung Vascular endothelial growth factor C Gene expression RNA interference Cell proliferation Apoptosis Neoplasm invasiveness
  • 相关文献

参考文献11

二级参考文献38

  • 1罗建民,刘泽林,郝洪岭,王福旭,董作仁,大野竜三.急性白血病细胞SHIP基因的突变分析[J].中华血液学杂志,2004,25(7):385-388. 被引量:13
  • 2温洪涛,张蕾,李继昌.基质金属蛋白酶-9和组织金属蛋白酶抑制剂-1在食管鳞癌中的表达[J].胃肠病学和肝病学杂志,2006,15(2):183-185. 被引量:4
  • 3蒋玉萍,吴小华.趋化因子CXCL12及其受体与肿瘤转移的关系[J].癌症,2007,26(2):220-224. 被引量:22
  • 4MASSAGUE J. G1 cell-cycle control and cancer [ J ]. Nature, 2004,432(7015 ) :298-306.
  • 5HIRSCH E, COSTA C, CIRAOLO E. Phosphoinositide 3-kinases as a common platform for multi-hormone signaling[ J]. J Endocrinol,2007,194 ( 2 ) : 243-256.
  • 6XU Q, SIMPSON SE, SCIALLA T J, et al. Survival of acute myeloid leukemia cells requries PI3 kinase activation [ J ]. Blood, 2003,102 ( 3 ) : 972-980.
  • 7GLOIRE G, CHARLIER E, RAHMOUNI S, et al. Restoration of SHIP-1 activity in human leukemic cells modifies NF-kB activation pathway and cellular survival upon oxidative stress[ J]. Oncogene, 2006,25 (40) :5485-5494.
  • 8GEIER S J, ALGATE PA, CARLBERG K, et al. The human SHIP gene is differentially expressed in cell lineages of the bone marrow and blood[J]. Blood, 1997, 89(6) :1876-1885.
  • 9LIU QR, SASAKI T, KOZIERADZKI I, et al. SHIP is negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival [ J ]. Genes Dev, 1999,13 ( 7 ) : 786 -791.
  • 10LUO J M, YOSHIDA H, KOMURA S, et al. Possible dominantnegative mutation of the SHIP gene in acute myeloid leukemia[J].Leukemia ,2003,17 ( 1 ) : 1-8.

共引文献66

同被引文献145

  • 1张慧冲.安徽国家重点保护野生植物的分布[J].黄山学院学报,2001,3(2):110-113. 被引量:4
  • 2Feng Y,Hu J,Ma J,et al.RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4,CCR7,VEGFR-2,and VEGFR-3-dependent axes-induced ERK,p38,and AKT signaling pathways[J].Eur J Cancer,2011,47(15):2353-2363.
  • 3Alitalo AK,Proulx ST,Karaman S,et al.VEGF-C and VEGF-D blockade inhibits inflammatory skin carcinogenesis[J].Cancer Res,2013,5:21.
  • 4Cao R,Bjorndahl MA,Religa P,et al.PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis[J].Cancer Cell,2004,6(4):333-345.
  • 5Hirakawa S,Kodama S,Kunstfeld R,et al.VEGF-A induces tumor and sentinel lymph node lymph angiogenesis and promotes lymphatic metastasis[J].J Exp Med,2005,201(7):1089-1099.
  • 6Joukov V,Sorsa T,Kumar V,et al.Proteolytic processing regulates receptor specificity and activity of VEGF-C[J].Embo J,1997,16(13):3898-3911.
  • 7Stacker SA,Stenvers K,Caesar C,et al.Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers[J].J Biol Chem,1999,274(45):32127-32136.
  • 8Rissanen TT,Markkanen JE,Gruchala M,et al.VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses[J].Circ Res,2003,92(10):1098-1106.
  • 9McColl BK,Baldwin ME,Roufail S,et al.Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D[J].J Exp Med,2003,198(6):863-868.
  • 10Houck KA,Leung DW,Rowland AM,et al.Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms[J].J Biol Chem,1992,267(36):26031-26037.

引证文献10

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部